PreviousEntry : {C5119E5B-9BBA-4948-BAB2-CC1A5B5A6E44} | Display Title : How are you responding to pharmacopoeia expectation of parenteral preparations?
NextEntry : {95D148CE-5EE1-4416-968F-23A1C251ACC5} | Display Title : How to Include Elastomers in the Nitrosamine Risk Assessment
Previous Next
Katie Espenshade

Katie Espenshade

Sr. Technical Account Manager, TCS, NA

Click here to receive updates on the latest posts on the WestPharma blog
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Reject